Abstract
Background: Exercise oximetry allows operator-independent recordings of microvascular blood flow impairments during exercise and can be used during upper arm provocative maneuvers.
Objective: To study the test-retest reliability of upper-limb oximetry during the Roos test in patients with suspected thoracic outlet syndrome (TOS).
Materials and Methods: Forty-two patients (28 men, 14 women; mean age: 40.8 years) were examined via transcutaneous oxygen pressure (TcpO2) recordings during two consecutive Roos tests in the standing position. The minimal decrease from rest of oxygen pressure (DROPmin) value was recorded after each maneuver was performed on both arms. The area under the receiver operating characteristic (ROC) curve defined the DROPmin diagnostic performance in the presence of symptoms during the tests. The Mann–Whitney U-test was used to compare the DROPmin in the symptomatic vs. asymptomatic arms. The test-retest reliability was analyzed with Bland-Altman representations. The results are presented as means ± standard deviations (SD) or medians [25–75 percentiles].
Results: The symptoms by history were different from the symptoms expressed during the Roos maneuvers in one-third of the patients. The DROPmin measurements were −19 [−36; −7] mmHg and −8 [−16; −5] mmHg in the symptomatic (n = 108) and asymptomatic (n = 60) arms, respectively. When TOS observed on ultrasound imaging was the endpoint, the area under the ROC curve (AUC) was 0.725 ± 0.058, with an optimal cutoff point of −15 mmHg. This value provided 67% sensitivity and 78% specificity for the presence TOS via ultrasound. When symptoms occurring during the test represented the endpoint, the AUC was 0.698 ± 0.04, with a cutoff point of −10 mmHg. This provided 62% sensitivity and 66% specificity for the presence of pain in the ipsilateral arm during the test. The test-retest reliability of DROPmin proved to be good but not perfect, partly because of unreliability of the provocation maneuvers.
Conclusion: To the best of our knowledge, this study is the first to investigate microvascular responses during the Roos maneuver in patients with suspected TOS. The presence of symptoms was significantly associated with ischemia. TcpO2 facilitated the recording of both macrovascular and microvascular responses to the Roos test. The Roos maneuver should probably be performed at least twice in patients with suspected TOS.
Introduction
Thoracic outlet syndrome (TOS) is one of the most controversial disorders in medicine, with multiple recent editorials having been published on the subject (Ahmad and Murthy, 2018; Burt, 2018; Illig, 2018). TOS comprises a variety of symptoms and physical findings resulting from the external compression of vessels and/or nerves as they pass through multiple narrow spaces between the thorax and the upper limb (Jubbal et al., 2018; Kaplan et al., 2018). As described by Demondion et al. (2006), the diagnosis is based on clinical findings, but making this diagnosis is often difficult. The use of imaging (radiography, ultrasonography, computed tomographic angiography, or magnetic resonance imagery) is required to determine the nature and location of the underlying structures causing the compression (Ammi et al., 2017).
Many provocative maneuvers have been proposed to induce dynamic compression of the neural or vascular structures. A provocative test was proposed by Roos in 1966, which is referred to as the “Roos test” or the “elevated arm stress test” (EAST). Beyond the reproduction of symptoms induced by the Roos test, an evaluation of perfusion via Doppler, pulse palpation, and/or observation of hand pallor are generally performed to detect arterial compression. However, coldness and color changes could also result from sympathetic vasoconstriction during neurogenic TOS (Sanders et al., 2007). In evaluating vasoconstrictive responses to adrenergic stimulation, the study of skin micro-circulation during provocative maneuvers could be of major interest in the study of TOS, at least for research purposes. To the best of our knowledge, such microvascular investigations have never been reported.
We aimed to evaluate the effects of the Roos (EAST) test on upper arm microcirculation using transcutaneous oxygen pressure (TcpO2) measurements. We hypothesized that this technique would be feasible and could account for both macrovascular and microvascular impairments. We also aimed at estimating the reliability of the responses observed in both unaffected patients and patients referred for suspected TOS. Last, we aimed to identify the preliminary results of preoperative versus postoperative evaluations.
Materials and Methods
From March 2018 to September 2018, 42 patients were recruited into this prospective single-center study.
Ethical Standards
The patients were fully informed about the study and its procedures; all patients signed a written consent document. This research and all its procedures were performed in compliance with the principles outlined in the Declaration of Helsinki. The study was promoted by the University Hospital in Angers, approved by our institutional Ethics Committee, and was registered in ClinicalTrials.gov under Ref: NCT03355274.
Experimental Design
The study population comprised patients referred to the Department of Vascular Medicine for suspected TOS. All subjects were over 18 years of age and there was no maximum age limit set. Exclusion criteria were: pregnancy, any legal constraint, or current participation in another clinical trial. To date, one female patient was referred to us for a new evaluation after a prior surgery. Results from this observation are provided to illustrate the presence or absence of persistent ischemia in the surgically treated arm.
Initial Assessment
At the point of study inclusion, we recorded patient demographics and conditions including: age, sex, presence of one or more cardiovascular risk factors (hypertension, diabetes mellitus, dyslipidemia, active smoking), history of chest or shoulder surgery, and any ongoing treatments. We also measured weight, height, systolic and diastolic blood pressures, and evaluated positional microvascular responses to the Roos test using transcutaneous oximetry (TcpO2) as described below. Results from ultrasound investigations performed prior to referral were encoded as “presence of absence of positive TO” on each side, according to the patient’s medical record. The technicians or physicians doing the TcpO2 test were blinded to these data.
Transcutaneous Oxygen Pressure Recordings
In brief, TcpO2 is a useful technique that measures the local skin oxygen partial pressure using electrochemical probes heated to 44.5°C to improve local perfusion and oxygen transcutaneous diffusion. TcpO2 changes, by calculating reductions in the rest of oxygen pressure (DROP) index, provide evidence of stimulation-induced regional blood flow impairments (Abraham et al., 2003, 2005; Bouye et al., 2004; Abraham, 2006; Henni et al., 2018). DROP is calculated as the limb level changes minus the changes at a reference chest electrode. DROP allows for removal of error due to unpredictable transcutaneous gradients (Abraham et al., 2003; Grouiller et al., 2006; Blake et al., 2018; Henni et al., 2018). In the present study, we positioned one probe 5–7 cm distal to the elbow joint at the proximal and internal portion of each forearm and one probe on the chest (parasternal) for reference. After a minimum of 15 min of heating, we started a 1-Hz recording with a 30-s reference period, after which patients performed two consecutive Roos tests. The second test was started after the DROP values returned to zero and after a minimum recovery period of 1 min following the end of the first test. Provocative maneuvers were conducted in the standing position with the patient’s back against a wall. The patients were required to raise their arms to 90 degrees of abduction, with the arms fully externally rotated and the elbows at 90 degrees of flexion. Further, we asked the patients to try to touch the wall behind them with their elbows and wrists, but not their back, to ensure that the arms were flexed slightly behind the frontal plane, as shown in Figure 1. This “surrender” or “candlestick” position with opening and closing of both hands was sustained in all patients to the point of maximum pain, or for a minimum of 2 min in the absence of pain. Patients were repeatedly asked to report any symptoms (pain, fatigue, numbness, or tingling) experienced during the Roos test on each arm. The minimum value of DROP (DROPmin) during or in the minute following the end of each Roos maneuver was recorded for each arm. Inherently, DROP is a negative value that decreases with the increase in the severity of ischemia (Abraham et al., 2005) and is expressed in millimeters of mercury (mmHg).
FIGURE 1
Statistical Analysis
The data are presented as numbers (percentages), medians [25, 75 percentiles], or means ± standard deviations (SD). A comparison of the DROPmin results between the symptomatic and asymptomatic arms was performed using the Wilcoxon rank test. A receiver operating characteristic (ROC) curve analysis comparing the DROPmin value to the presence/absence of symptoms was used to define the optimal cutoff point for the DROPmin values in the prediction of symptom occurrence. All statistical analyses were performed using SPSS (IBM SPSS statistics V15.0, Chicago, IL, United States). P < 0.05 was considered to be statistically significant. The area under the ROC curve (AUC) was used to determine whether DROP significantly predicted positive results on ultrasound imaging and/or the presence of symptoms during the Roos test. The optimal cutoff point was defined as the DROP value that resulted in the minimum distance to the 100% sensitivity / 100% specificity angle. The test-retest reliability of the DROP results observed for two consecutive Roos tests was analyzed using a Bland-Altman representation with logarithmic (10-log) transform in cases of heteroscedasticity, according to recommendations (Euser et al., 2008; Ludbrook, 2010). To create the 10-log transformation, DROPmin values were converted into absolute values (positive values). The absence of a decrease in DROP was encoded by −1 mmHg and not zero. Last, the test-retest reliability of TcpO2 was evaluated according to the similarity of symptoms between test 1 and test 2. Indeed, if discomfort or pain was present during one of the maneuvers, but absent during the other one, the TcpO2 difference was expected to have resulted from unsatisfactory maneuver reproduction, with the presence of compression during one test and the absence of compression during the other.
Results
The recruited patients included 28 men and 14 women, aged 40.8 ± 12.2 years old. The mean weight was 70.3 ± 16 kg and mean height was 164 ± 7 cm. Fifteen patients had one or more cardiovascular risk factors and 12 had a prior history of chest or shoulder surgery. Ongoing treatments included the use of lipid-lowering drugs (n = 2) and sartans (n = 2). Systolic and diastolic arm blood pressures were 126 ± 14 and 79 ± 11 mmHg, respectively. Among these patients, 15 reported unilateral symptoms on the right (n = 7) or left (n = 8) side and 27 reported bilateral symptoms. Among the patients reporting unilateral symptoms, 5 had previously undergone surgery for contralateral TOS. Among patients with unilateral symptoms, Roos maneuvers induced unilateral (n = 8) or bilateral (n = 5) pain. In two patients, the Roos maneuver did not reproduce the usual symptoms. Interestingly, among patients with unilateral symptoms, when the results were analyzed arm by arm, the symptoms were present in two consecutive tests in 8 patients, in neither of the tests in 5, and in one test only in 17 (in solely the first test in 8, and in solely the second test in 9). Of the 27 patients referred for bilateral symptoms, 2 had undergone previous unilateral (n = 1) or bilateral (n = 1) surgery for TOS. Among these patients, the Roos maneuvers induced unilateral (n = 6) or bilateral (n = 20) pain. In one patient, the Roos maneuvers did not reproduce the usual symptoms. Notably, when the 54 arms of the patients with bilateral symptoms were analyzed arm by arm, the symptoms were present during two consecutive tests in 31 patients, during neither test in 10, during solely the first test in 8, and during solely the second test in 5. Of 42 patients, ultrasounds were positive for TOS on one or both sides in only 25 of them, as shown in Table 1.
Table 1
| Positive ultrasound results | |||||
|---|---|---|---|---|---|
| None | Right | Left | Bilateral | ||
| Symptoms by history | Right | 2 | 3 | 0 | 2 |
| Left | 3 | 2 | 3 | 0 | |
| Bilateral | 12 | 2 | 4 | 9 | |
Distribution of symptoms by history and results of ultrasound investigations in the studied population.
TcpO2 showed excellent feasibility, with no technical failures or missing values. The chest TcpO2 value at rest was 69 ± 10 mmHg. TcpO2 at rest in the symptomatic (69 values) and asymptomatic (15 values) arms were 76 ± 12 and 74 ± 10 mmHg, respectively (p > 0.05). A typical example of a recording in a patient with TOS is presented in Figure 2. As shown, the Roos maneuvers were responsible for a sharp decrease in the right and left DROP values, although they were slightly decreased during the second maneuver on the left arm.
FIGURE 2
The lowest DROPmin values of the two tests were as follows: −12 [−21, −7] mmHg in the arm with an absence of TOS findings on ultrasound imaging and −27 [−50, −14] mmHg in the arms with ultrasound evidence of TOS (p < 0.01). When TOS identified on ultrasound imaging was the endpoint, the AUC was 0.725 ± 0.058 (p < 0.001 from random choice), with an optimal cutoff point of −15 mmHg providing 67% sensitivity and 78% specificity for the presence of TOS on ultrasound.
On average, the DROPmin values were as follows: −14 [−26, −6] mmHg for test 1 and −13 [−27, −7] mmHg for test 2 (p > 0.05) on the right side; −13 [−27, −7] mmHg for test and −11 [−29, −6] mmHg for test 2 on the left side. On an arm-by-arm basis, among the 168 available values (42 patients, 2 arms, 2 tests), the DROPmin values measured in the symptomatic (108 values) and asymptomatic (60 values) arms were −19 [−36, −7] mmHg and −8 [−16, −5] mmHg, respectively (p < 0.001). When the presence of symptoms during the test was the endpoint, the AUC was 0.698 ± 0.04 (p < 0.001 from random choice), with a cutoff point of −10 mmHg providing 62% sensitivity and 66% specificity for the presence of pain in the ipsilateral arm during the test.
For the entire test series, the average difference between the DROPmin results of test 2 vs. test 1 on a Bland-Altman representation showed a clear heteroscedastic distribution with a mean difference of 1.2 mmHg. Figure 3 shows the 10-log transformed data, confirming good agreement between the two tests (despite outlier values), with a mean difference close to zero and reasonable limits of agreements (LA).
FIGURE 3
Finally, the patient presented in Figure 2 had a second test prior to surgery (Figure 4, upper panel), confirming the results of the first test, and then had surgery on the right (dominant) side by an axillary approach. She was referred 3 months after surgery with complete relief of symptoms in the right arm and normalization of the DROPmin on the right side (Figure 4, lower panel). Because her left arm was only moderately symptomatic after surgery, she was unwilling to undergo a second operation.
FIGURE 4
Discussion
To the best of our knowledge, this study is the first to investigate microvascular responses during the Roos test, one of the most largely used provocative maneuvers in the diagnosis of TOS. This study provides evidence that the technique is both feasible and reliable. Further, preliminary results suggest that it is sensitive to the changes observed after surgery.
Positive tests suggesting the presence of arterial, and/or venous, and /or nerve compressions are frequently observed in the general population. Using photo-plethysmography (PPG) in 130 apparently unaffected individuals, arterial obstructions were identified in 78 of them (60%) (Gergoudis and Barnes, 1980). Abnormal ultrasound or arterial PPG findings on the EAST and Upper Limb Tension Test (ULTT) were observed in 69% of 64 high-performance string instrument musicians, in contrast to 15% of 22 control subjects (Adam et al., 2018). Arterial flow anomalies on Doppler ultrasound and PPG were identified in 13% of 100 limbs from 50 normal volunteers (Chen et al., 2014). In 98 dissections of the thoracic outlet from 50 unselected cadavers, Juvonen et al. (1995) observed 63% with abnormal anatomy and 10% (5/50) had bilaterally normal anatomy. Thus, most neurovascular compressions remain asymptomatic and the specificity of tests will never reach 100% if symptoms are used as gold-standard endpoints.
There are conflicting results about the respective prevalences of arterial (ATOS), venous (VTOS), and neurogenic (NTOS) types of TOS and “combined” / “disputed” types (Ferrante and Ferrante, 2017; Peek et al., 2018). Relative ATOS, VTOS, and NTOS prevalences seem to partially rely on how each form is defined. Restricting arterial TOS to embolic events and venous TOS to Paget-Schroetter thromboembolic complications, as proposed by Sanders et al. (2007), leads to the consideration that over 95% of all TOS are neurogenic and less than 1% are arterial. Other series have reported more balanced results, using less restrictive definitions for ATOS and VTOS with results ranging from 48.7 to 74% of NTOS, 22 to 44% VTOS, and 4 to 25% ATOS (Ann Freischlag, 2018; Henry et al., 2018; Likes et al., 2014). Finally, whatever the definitions used and the exact proportions of each TOS type, the diagnosis of compression has generally been based on non-invasive clinical signs and vascular investigations.
Clinical provocative tests are considered to be of limited sensitivity and specificity (Warrens and Heaton, 1987; Gillard et al., 2001), probably partially resulting from a high rate of positive results in apparently asymptomatic patients, as previously discussed (Nord et al., 2008); however, it may also possibly result from a low test-retest reliability of the provocative maneuvers (Warrens and Heaton, 1987; Nord et al., 2008). No single non-invasive technique seems to be optimal for diagnosing TOS. One of the most widely used and useful tests for diagnosing TOS is ultrasonography. Unfortunately, preoperative duplex ultrasounds are only 41% sensitive for the diagnosis of NTO (Orlando et al., 2016). Ultrasonography only has a sensitivity of 87% and specificity of 88%, with risks of false-positive and false-negative results (Gillard et al., 2001). False-positive tests are assumed to result from signal losses or, when compared to the presence of symptoms by history, from the possibility of compression in asymptomatic – assumed healthy – individuals. False-negative tests could result either from non-adapted maneuvers, insufficient practitioner experience, or inadequate technical recording. Magnetic resonance imaging (MRI) sensitivity, specificity, and positive and negative predictive values have been reported to be 41, 33, 89, and 4%, respectively (Singh et al., 2014). Whatever the technique, assuming that coldness and color changes would not be caused by ischemia resulting from subclavian artery obstruction, but from an overactive sympathetic nervous system (Sanders et al., 2007), Doppler ultrasonography would not adequately detect neurally induced cutaneous vasoconstriction. Whether or not pallor and coldness are always of neural origin, the specific benefit of TcpO2 is that it can monitor both macro- and microvascular responses according to TcpO2 decreases at arm level. These responses reflect cutaneous flow changes from the eventual occlusion of proximal vessels and the eventual reduction in skin blood flow secondary to sympathetic nervous system-induced vasoconstriction. The specific interest in TcpO2 is that it is expected to decrease in cases of arterial compression (Babilas et al., 2008), secondary to neurally induced vasoconstriction (Provenzano et al., 2008) and isolated venous occlusion (Ostergren et al., 1983; Geis et al., 2008).
To the best of our knowledge, no other research has investigated upper limb TcpO2 during provocative tests to evaluate TOS. Transcutaneous oxygen pressure changes have been well-described at rest and during exercise (Abraham et al., 2003). During exercise, this measurement was shown to be both accurate and reliable in the evaluation of exercise-induced ischemia (Abraham et al., 2003, 2005; Bouye et al., 2004; Abraham, 2006; Henni et al., 2018). Although absolute TcpO2 has shown fair reliability (Rooke and Osmundson, 1989; Daviet et al., 2004), the calculation of the DROP index improved reliability in test–retest recordings (Bouye et al., 2004). In the present study, TcpO2 facilitated the measurement of regional blood flow impairments, regardless of the underlying mechanism, and showed satisfactory reliability. Importantly, the −15 mmHg cutoff point, using ultrasound results as a reference, is similar to the one identified from exercise TcpO2 measurements (Abraham et al., 2003; Grouiller et al., 2006; Audonnet et al., 2017; Henni et al., 2018). Determining the cutoff point is important because limb elevation physiologically decreases TcpO2 as hydrostatic pressure decreases (Dooley et al., 1997; Shah et al., 2008).
The present study had some limitations. First, we did not monitor the positions of the patients using three-dimensional cameras or accelerometers. This would be useful for excluding the ∼15% inconsistent test-retest results that relied on an imperfect reproducibility of carefully performed provocative maneuvers. Our opinion is that although provocative maneuvers were very carefully supervised, even non-measurable minor changes in position and intensity of shoulder muscle contractions could result in variable compressive effects. Similarly, we believe that the inconsistent test-retest results were not due to the technique itself, because TcpO2 changes during exercise-induced ischemia are highly reliable and operator-independent (Henni et al., 2018).
Second, we could not confirm the presence or absence of arterial compression using contrast-enhanced imaging in many of the patients. One reason for this was that most patients with positive tests were referred to physical therapy or declined surgery. Radiological imaging in such patients is not indicated. Further, admitting that pallor and coldness did not systematically result from arterial compression, but rather resulted from neurovascular vasoconstriction during nerve compression, indicated that contrast-enhanced imaging techniques should no longer be considered gold-standard techniques. This would be a limitation if our main goal was to evaluate the diagnostic performance of the TcpO2 technique compared to a gold standard. However, this was not our goal. We only intended to test the feasibility and reliability of the technique. Nevertheless, the postoperative results in one of our patients confirmed that DROPmin values improve after surgery.
Third, we only tested the Roos maneuver, although other tests have been proposed to facilitate the diagnosis of TOS. Our choice was deliberate here, and relates to the fact that the Roos maneuver is generally reported as the one that provides a greater number of positive results (Rayan and Jensen, 1995; Nord et al., 2008). Future studies should evaluate the Tcpo2 response to other tests.
Finally, TcpO2 is not considered a routine tool because of the cost of the device and the length of time required to reach stable values, specifically at arm level (Gorska et al., 2015; Chiang et al., 2018). Nevertheless, the diagnosis of TOS should be based on a holistic approach that includes the patient’s history, clinical examination, and minimally invasive investigations. TcpO2 could provide additional non-invasive evidence of abnormal microvascular responses to provocative tests (at least for the Roos test) before radiological imaging is chosen in cases of inefficient physiotherapy.
Conclusion
In conclusion, to the best of our knowledge, this study is the first to examine microvascular responses during the Roos maneuver in patients with suspected TOS. However, additional studies with a larger number of patients are needed to evaluate the performance of TcpO2 with respect to making the diagnosis of TOS. These studies should compare the test results to a gold standard, analyze the test-retest reproducibility, evaluate the responses to other provocative maneuvers, and estimate its sensitivity to the treatment of neural and/or vascular compression of the outlet. The Roos maneuver should probably be performed at least twice in patients with suspected TOS because of the moderate test-retest reliability of symptoms induced by the Roos test, even during carefully supervised maneuvers. TcpO2 appears to be a promising non-operator-dependent investigative tool that allows for the simultaneous analysis of both arms during dynamic maneuvers in the standing position and investigations of the microvascular response to the Roos test. This might contribute to a holistic approach toward patients with suspected TOS.
Statements
Author contributions
SH, JH, MA, F-EM, JP, and PA participated in patient recruitment, data acquisition, data analysis, and patient treatment. SH and PA participated in the preparation of the study and provided technical and administrative support for the project. JH, JP, and PA supervised the project. SH, JH, JP, and PA wrote the manuscript. MA and F-EM reviewed and critically revised the draft. All authors approved the final version of the manuscript.
Acknowledgments
The authors thank Marine Mauboussion and Stéphanie Marechal for their technical assistance. The authors also thank Editage® for grammar and style reviewing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AbrahamP. (2006). Validation of a new device for transcutaneous oxygen pressure recordings in real and simulated exercise tests.Med. Sci. Sports Exerc.25190–196.
2
AbrahamP.PicquetJ.BouyeP.L’HosteP.EnonB.VielleB.et al (2005). Transcutaneous oxygen pressure measurements (tcpO2) at ankle during exercise in arterial claudication.Int. Angiol.2480–88.
3
AbrahamP.PicquetJ.VielleB.Sigaudo-RousselD.Paisant-ThouvenyF.EnonB.et al (2003). Transcutaneous oxygen pressure measurements on the buttocks during exercise to detect proximal arterial ischemia: comparison with arteriography.Circulation1071896–1900. 10.1161/01.CIR.0000060500.60646.E0
4
AdamG.WangK.DemareeC. J.JiangJ. S.CheungM.BecharaC. F.et al (2018). A prospective evaluation of duplex ultrasound for thoracic outlet syndrome in high-performance musicians playing bowed string instruments.Diagnostics8:E11. 10.3390/diagnostics8010011
5
AhmadU.MurthyS. C. (2018). Who should be “let in” when managing the thoracic outlet?J. Thorac. Cardiovasc Surg.1561324–1325. 10.1016/j.jtcvs.2018.05.035
6
AmmiM.PeretM.HenniS.DaligaultM.AbrahamP.PaponX.et al (2017). Frequency of the pectoralis minor compression syndrome in patients treated for thoracic outlet syndrome.Ann. Vasc. Surg.47253–259. 10.1016/j.avsg.2017.09.002
7
Ann FreischlagJ. A. (2018). Decade of excellent outcomes after surgical intervention: 538 patients with thoracic outlet syndrome.Trans. Am. Clin. Climatol. Assoc.12988–94.
8
AudonnetM.SignoletI.Colas-RibasC.AmmiM.AbrahamP.HenniS. (2017). Exercise transcutaneous oximetry of the buttocks- external validation with computed tomography angiography.Circ. J.811123–1128. 10.1253/circj.CJ-16-1316
9
BabilasP.LambyP.PrantlL.SchremlS.JungE. M.LiebschG.et al (2008). Transcutaneous pO2 imaging during tourniquet-induced forearm ischemia using planar optical oxygen sensors.Skin Res. Technol.14304–311. 10.1111/j.1600-0846.2008.00295.x
10
BlakeD. F.YoungD. A.BrownL. H. (2018). Transcutaneous oximetry: variability in normal values for the upper and lower limb.Diving Hyperb. Med.482–9. 10.28920/dhm48.1.2-9
11
BouyeP.PicquetJ.JaquinandiV.EnonB.LeftheriotisG.SaumetJ. L.et al (2004). Reproducibility of proximal and distal transcutaneous oxygen pressure measurements during exercise in stage 2 arterial claudication.Int. Angiol.23114–121.
12
BurtB. M. (2018). Thoracic outlet syndrome for thoracic surgeons.J. Thorac. Cardiovasc. Surg.1561318.e1–1323.e1. 10.1016/j.jtcvs.2018.02.096
13
ChenH.DoornbosN.WilliamsK.CriadoE. (2014). Physiologic variations in venous and arterial hemodynamics in response to postural changes at the thoracic outlet in normal volunteers.Ann. Vasc. Surg.281583–1588. 10.1016/j.avsg.2014.05.003
14
ChiangN.JainJ. K.SleighJ.VasudevanT. (2018). Measuring transcutaneous oxygenation to validate the duration required to achieve electrode equilibration.Adv. Skin Wound Care31263–269. 10.1097/01.ASW.0000530847.49484.4b
15
DavietJ. C.DudognonP.PreuxP. M.RebeyrotteI.LacroixP.MunozM.et al (2004). Reliability of transcutaneous oxygen tension measurement on the back of the hand and complex regional pain syndrome after stroke.Arch. Phys. Med. Rehabil.851102–1105. 10.1016/j.apmr.2003.09.034
16
DemondionX.HerbinetP.Van Sint JanS.BoutryN.ChantelotC.CottenA. (2006). Imaging assessment of thoracic outlet syndrome.Radiographics261735–1750. 10.1148/rg.266055079
17
DooleyJ.KingG.SladeB. (1997). Establishment of reference pressure of transcutaneous oxygen for the comparative evaluation of problem wounds.Undersea Hyperb. Med.24235–244.
18
EuserA. M.DekkerF. W.le CessieS. A. (2008). A practical approach to bland-altman plots and variation coefficients for log transformed variables.J. Clin. Epidemiol.61978–982. 10.1016/j.jclinepi.2007.11.003
19
FerranteM. A.FerranteN. D. (2017). The thoracic outlet syndromes: part 1. Overview of the thoracic outlet syndromes and review of true neurogenic thoracic outlet syndrome.Muscle Nerve55782–793. 10.1002/mus.25536
20
GeisS.BabilasP.SchremlS.AngeleP.NerlichM.JungE. M.et al (2008). Transcutaneous pO2 measurement during tourniquet-induced venous occlusion using dynamic phosphorescence imaging.Clin. Hemorheol. Microcirc40249–258.
21
GergoudisR.BarnesR. W. (1980). Thoracic outlet arterial compression: prevalence in normal persons.Angiology31538–541. 10.1177/000331978003100805
22
GillardJ.Perez-CousinM.HachullaE.RemyJ.HurteventJ. F.VinckierL.et al (2001). Diagnosing thoracic outlet syndrome: contribution of provocative tests, ultrasonography, electrophysiology, and helical computed tomography in 48 patients.Joint Bone Spine68416–424. 10.1016/S1297-319X(01)00298-6
23
GorskaK.KorczynskiP.Maskey-WarzechowskaM.ChazanR.KrenkeR. (2015). Variability of transcutaneous oxygen and carbon dioxide pressure measurements associated with sensor location.Adv. Exp. Med. Biol.85839–46. 10.1007/5584_2015_126
24
GrouillerF.JaquinandiV.PicquetJ.SoudayV.SaumetJ. L.AbrahamP. (2006). Validation of a new device for transcutaneous oxygen pressure recordings in real and simulated exercise tests.Int. Angiol.25190–196.
25
HenniS.SemporeY. W.Le MelinerT.OuedraogoN.HamelJ. F.AbrahamP. (2018). Intra-test and test-retest reliability of exercise oximetry in arterial claudication.Microvasc. Res.11744–49. 10.1016/j.mvr.2018.01.003
26
HenryB. M.VikseJ.SannaB.TaterraD.GomulskaM.PekalaP. A.et al (2018). Cervical rib prevalence and its association with thoracic outlet syndrome: a meta-analysis of 141 studies with surgical considerations.World Neurosurg.110e965–e978. 10.1016/j.wneu.2017.11.148
27
IlligK. A. (2018). Neurogenic thoracic outlet syndrome: bringing order to chaos.J. Vasc. Surg.68939–940. 10.1016/j.jvs.2018.04.030
28
JubbalK. T.ZavlinD.HarrisJ. D.LibermanS. R.EchoA. (2018). Morbidity of first rib resection in the surgical repair of thoracic outlet syndrome.Hand [Epub ahead of print] 10.1177/1558944718760037
29
JuvonenT.SattaJ.LaitalaP.LuukkonenK.NissinenJ. (1995). Anomalies at the thoracic outlet are frequent in the general population.Am. J. Surg.17033–37. 10.1016/S0002-9610(99)80248-7
30
KaplanT.ComertA.EsmerA. F.AtacG. K.AcarH. I.OzkurtB.et al (2018). The importance of costoclavicular space on possible compression of the subclavian artery in the thoracic outlet region: a radio-anatomical study.Interact. Cardiovasc Thorac. Surg.27561–565. 10.1093/icvts/ivy129
31
LikesK.RochlinD. H.SalditchQ.DapashT.BakerY.DeGuzmanR.et al (2014). Diagnostic accuracy of physician and self-referred patients for thoracic outlet syndrome is excellent.Ann. Vasc. Surg.281100–1105. 10.1016/j.avsg.2013.12.011
32
LudbrookJ. (2010). Confidence in Altman-Bland plots: a critical review of the method of differences.Clin. Exp. Pharmacol. Physiol37143–149. 10.1111/j.1440-1681.2009.05288.x
33
NordK. M.KapoorP.FisherJ.ThomasG.SundaramA.ScottK.et al (2008). False positive rate of thoracic outlet syndrome diagnostic maneuvers.Electromyogr. Clin. Neurophysiol.4867–74.
34
OrlandoM. S.LikesK. C.MirzaS.CaoY.CohenA.LumY. W.et al (2016). Preoperative duplex scanning is a helpful diagnostic tool in neurogenic thoracic outlet syndrome.Vasc. Endovascular Surg.5029–32. 10.1177/1538574415623650
35
OstergrenJ.SvedmanP.FagrellB. (1983). The influence of venous and arterial occlusion on capillary blood flow and transcutaneous oxygen tension in fingers.Int. J. Microcirc. Clin. Exp.2315–324.
36
PeekJ.VosC. G.UnluC.SchreveM. A.van de MortelR. H. W.de VriesJ. P. M. (2018). Long-term functional outcome of surgical treatment for thoracic outlet syndrome.Diagnostics8:E7. 10.3390/diagnostics8010007
37
ProvenzanoD. A.JarzabekG.GeorgevichP. (2008). The utilization of transcutaneous oxygen pressures to guide decision-making for spinal cord stimulation implantation for inoperable peripheral vascular disease: a report of two cases.Pain Physician11909–916.
38
RayanG. M.JensenC. (1995). Thoracic outlet syndrome: provocative examination maneuvers in a typical population.J. Shoulder Elbow Surg.4113–117. 10.1016/S1058-2746(05)80064-3
39
RookeT. W.OsmundsonP. J. (1989). Variability and reproducibility of transcutaneous oxygen tension measurements in the assessment of peripheral vascular disease.Angiology40695–700. 10.1177/000331978904000802
40
SandersR. J.HammondS. L.RaoN. M. (2007). Diagnosis of thoracic outlet syndrome.J. Vasc. Surg.46601–604. 10.1016/j.jvs.2007.04.050
41
ShahJ. B.RamD. M.FredrickE.OttoG. H.SheffieldP. J. (2008). Determination of ideal PtcO2 measurement time in evaluation of hypoxic wound patients.Undersea Hyperb. Med.3541–51.
42
SinghV. K.JeyaseelanL.KyriacouS.GhoshS.SinisiM.FoxM. (2014). Diagnostic value of magnetic resonance imaging in thoracic outlet syndrome.J. Orthop. Sur.22228–231. 10.1177/230949901402200224
43
WarrensA. N.HeatonJ. M. (1987). Thoracic outlet compression syndrome: the lack of reliability of its clinical assessment.Ann. R. Coll. Surg. Engl.69203–204.
Summary
Keywords
peripheral artery disease, exercise, provocative maneuvers, ischemia, microcirculation, oximetry
Citation
Henni S, Hersant J, Ammi M, Mortaki F-E, Picquet J, Feuilloy M and Abraham P (2019) Microvascular Response to the Roos Test Has Excellent Feasibility and Good Reliability in Patients With Suspected Thoracic Outlet Syndrome. Front. Physiol. 10:136. doi: 10.3389/fphys.2019.00136
Received
26 October 2018
Accepted
06 February 2019
Published
21 February 2019
Volume
10 - 2019
Edited by
Helena Lenasi, University of Ljubljana, Slovenia
Reviewed by
Claudia Penna, University of Turin, Italy; Ferenc Bari, University of Szeged, Hungary
Updates
Copyright
© 2019 Henni, Hersant, Ammi, Mortaki, Picquet, Feuilloy and Abraham.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Pierre Abraham, piabraham@chu-angers.fr
This article was submitted to Vascular Physiology, a section of the journal Frontiers in Physiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.